Stockscreener 앱 받기
58.88
2.45%
-1.48
시간 외 거래:
58.88
전일 마감가:
$60.36
열려 있는:
$60.36
하루 거래량:
3.11M
Relative Volume:
1.34
시가총액:
$7.34B
수익:
$692.26M
순이익/손실:
$-512.41M
주가수익비율:
-13.89
EPS:
-4.24
순현금흐름:
$-274.36M
1주 성능:
+8.57%
1개월 성능:
+22.44%
6개월 성능:
+22.36%
1년 성능:
+106.31%
1일 변동 폭
$58.59
$60.67
1주일 범위
$53.29
$60.68
52주 변동 폭
$20.14
$60.68
가든트헬스 Stock (GH) Company Profile
명칭
Guardant Health Inc
전화
855-698-8887
주소
3100 HANOVER STREET, PALO ALTO
GH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GH
Guardant Health Inc
|
58.88 | 7.53B | 692.26M | -512.41M | -274.36M | -4.24 |
|
TMO
Thermo Fisher Scientific Inc
|
489.01 | 183.16B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
210.93 | 150.53B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
650.84 | 52.32B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
119.20 | 33.77B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
191.09 | 32.20B | 15.50B | 1.33B | 2.16B | 7.34 |
가든트헬스 Stock (GH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-10 | 개시 | Mizuho | Outperform |
| 2025-01-23 | 개시 | Barclays | Overweight |
| 2024-06-28 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2024-06-03 | 재개 | Jefferies | Buy |
| 2024-04-24 | 재개 | Craig Hallum | Buy |
| 2023-12-14 | 개시 | Guggenheim | Neutral |
| 2023-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2023-11-13 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2023-09-28 | 개시 | Bernstein | Outperform |
| 2023-09-27 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-05-26 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-05-05 | 개시 | UBS | Buy |
| 2023-03-09 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2023-01-05 | 개시 | Scotiabank | Sector Outperform |
| 2022-11-01 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-10-19 | 개시 | Craig Hallum | Buy |
| 2022-10-06 | 개시 | Stephens | Overweight |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-06-03 | 개시 | Piper Sandler | Overweight |
| 2022-04-28 | 재개 | BTIG Research | Buy |
| 2022-02-24 | 재확인 | Canaccord Genuity | Buy |
| 2022-02-24 | 재확인 | Citigroup | Buy |
| 2022-02-24 | 재확인 | Cowen | Outperform |
| 2022-02-24 | 재확인 | Morgan Stanley | Overweight |
| 2022-02-24 | 재확인 | SVB Leerink | Outperform |
| 2022-02-24 | 재확인 | Stifel | Buy |
| 2022-02-24 | 재확인 | Wells Fargo | Overweight |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-06-15 | 개시 | Raymond James | Mkt Perform |
| 2021-06-03 | 개시 | Goldman | Buy |
| 2021-05-25 | 개시 | Wells Fargo | Overweight |
| 2021-01-11 | 개시 | Stifel | Buy |
| 2020-09-09 | 개시 | Morgan Stanley | Overweight |
| 2020-06-12 | 개시 | BTIG Research | Buy |
| 2020-02-21 | 개시 | Guggenheim | Buy |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2019-08-07 | 재확인 | Canaccord Genuity | Buy |
| 2019-04-16 | 개시 | Canaccord Genuity | Buy |
| 2019-04-10 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-02-28 | 재확인 | BofA/Merrill | Neutral |
| 2018-10-29 | 개시 | BofA/Merrill | Neutral |
| 2018-10-29 | 개시 | JP Morgan | Overweight |
| 2018-10-29 | 개시 | William Blair | Outperform |
모두보기
가든트헬스 주식(GH)의 최신 뉴스
Is Guardant Health Inc. impacted by rising ratesCEO Change & Real-Time Stock Movement Alerts - thegnnews.com
Detecting price anomalies in Guardant Health Inc. with AI2025 Breakouts & Breakdowns & Intraday High Probability Alerts - Newser
Can machine learning forecast Guardant Health Inc. recovery2025 Biggest Moves & AI Powered Market Entry Strategies - Newser
Live market analysis of Guardant Health Inc.2025 Key Lessons & Low Risk High Win Rate Picks - Newser
Can Guardant Health Inc. hit a new high this monthSwing Trade & Fast Momentum Stock Entry Tips - Newser
Guardant Health Inc. Stock Approaches Key Moving Average2025 Bull vs Bear & Long Hold Capital Preservation Tips - metal.it
Will Guardant Health Inc. rebound enough to break evenJuly 2025 Decliners & Precise Entry and Exit Recommendations - Newser
Can Guardant Health Inc. be recession proof2025 Stock Rankings & Verified Short-Term Trading Plans - thegnnews.com
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - 01net
What’s the analyst consensus on Guardant Health Inc.July 2025 Review & Weekly Setup with ROI Potential - kangso.co.kr
Market Participants Recognise Guardant Health, Inc.'s (NASDAQ:GH) Revenues Pushing Shares 26% Higher - 富途牛牛
Guardant Health Hits 52-Week High on $210M Volume Ranking 463rd Amid Institutional BuySell Splits - AInvest
Guardant Health stock reaches 52-week high at 59.25 USD By Investing.com - Investing.com Nigeria
Guardant Health stock reaches 52-week high at 59.25 USD - Investing.com
Cathie Wood’s ARK buys Bullish stock, sells Shopify and Guardant Health - Investing.com India
Astrana Health, agilon health, Guardant Health, AdaptHealth, and Pediatrix Medical Group Stocks Trade Up, What You Need To Know - Yahoo Finance
Astrana Health, agilon health, Guardant Health, AdaptHealth, and Pediatrix Medical Group Stocks Trade Up, What You Need To Know | FinancialContent - FinancialContent
Guardant Health at Canaccord Conference: Strategic Growth Unveiled By Investing.com - Investing.com Canada
GH Q2 Deep Dive: Strong Volume Growth and Product Expansion Amid Profitability Challenges - Yahoo Finance
The 5 Most Interesting Analyst Questions From Guardant Health’s Q2 Earnings Call - Yahoo Finance
Multi Cancer Early Detection Market Forecast Report 2025-2033: A $4.3 Billion Market by 2033, as Market Set to Quadruple from $1 Billion Valuation in 2024 - uk.finance.yahoo.com
Exact Sciences Teams Up With Freenome to Take on Guardant Health in Colorectal Cancer Screening - MedCity News
Weekly Market Update: Stocks Rise as Basic Materials and Tech Gain - Morningstar
Guardant Health Surges 7.62% on $250M Volume Despite 396th Market Activity Rank - AInvest
Guardant Health Surges 13% on 197% Volume Spike Ranks 269th in Market Activity - AInvest
Guardant Health stock hits 52-week high at 53.49 USD By Investing.com - Investing.com South Africa
Guardant Health stock hits 52-week high at 53.49 USD - Investing.com
Guardant Health Soars 17.2% on Q2 Earnings Beat - AInvest
Exact Sciences acquires rights to rival Freenome’s blood-based colon cancer test - statnews.com
Multi-Cancer Early Detection Market Set to Revolutionize Cancer Diagnosis by 2034 | Driven by Liquid Biopsy Innovations and AI Integration - PharmiWeb.com
The Oncology Institute, Inc. shares rise 3.94% intraday after American Cancer Society and Guardant Health partnership. - AInvest
American Cancer Society and Guardant Health Partner to Expand Cancer Screening Access and Advance Health Equity - Business Wire
Is It Too Late to Sell Guardant Health Inc.Intraday Trend Analysis for Fast Gains Released - beatles.ru
Why is Guardant Health Inc. stock attracting strong analyst attentionRobust financial gains - Jammu Links News
What drives Guardant Health Inc. stock priceUnlock daily market insights for better trades - Jammu Links News
What is the risk reward ratio of investing in Guardant Health Inc. stockExceptional market positioning - Jammu Links News
Should I hold or sell Guardant Health Inc. stock in 2025Maximize portfolio value with expert tips - Jammu Links News
What catalysts could drive Guardant Health Inc. stock higher in 2025Exceptional trading results - Jammu Links News
How volatile is Guardant Health Inc. stock compared to the marketHarness the power of proven investment plans - Jammu Links News
What institutional investors are buying Guardant Health Inc. stockSignificant capital appreciation - Jammu Links News
Does Guardant Health Inc. stock perform well during market downturnsUnlock powerful portfolio management tools - Jammu Links News
What is Guardant Health Inc. company’s growth strategyMarket-leading growth rates - Jammu Links News
Is Guardant Health Inc. a growth stock or a value stockRapid growth trajectories - Jammu Links News
What are Guardant Health Inc. company’s key revenue driversStrong return on assets - Jammu Links News
Is Guardant Health Inc. stock overvalued or undervaluedAchieve breakthrough performance with smart picks - Jammu Links News
How many analysts rate Guardant Health Inc. as a “Buy”Unlock powerful portfolio management tools - Jammu Links News
Guardant Health (GH) introduces IHC Solid Tumor Testing to its Portfolio - MSN
Guardant Health, Inc. (NASDAQ:GH) Q2 2025 Earnings Call Transcript - Insider Monkey
Guardant Health Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Guardant Health Reports Strong Q2 2025 Growth - The Globe and Mail
Guardant Health Beat Wall Street Expectations And Raised Its Outlook - Finimize
가든트헬스 (GH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.67%
0.75%
자본화:
|
볼륨(24시간):